CLEC10A and glioblastoma: HML-2 maintains glioblastoma stemness and tumorigenesis, transcriptionally activates ESC programs in NPC-derived astrocytes, and alters their 3D cellular morphology by activating the nuclear transcription factor OCT4 [95].